Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Structure-activity study on a series of α-glutamic acid scaffold based compounds as new ADAMTS inhibitors.

Peng L, Duan L, Liu X, Shen M, Li Y, Yan J, Li H, Ding K.

Bioorg Med Chem Lett. 2011 Aug 1;21(15):4457-61. doi: 10.1016/j.bmcl.2011.06.009. Epub 2011 Jun 16.

PMID:
21733683
2.

[Aggrecanases and osteoarthritis].

Li C, Cao YP, Guan ZP, Huang de Y, Ge ZG.

Beijing Da Xue Xue Bao. 2009 Oct 18;41(5):611-2. Review. Chinese.

3.

Aggrecanase and aggrecan degradation in osteoarthritis: a review.

Huang K, Wu LD.

J Int Med Res. 2008 Nov-Dec;36(6):1149-60. Review.

PMID:
19094423
4.

Drug insight: aggrecanases as therapeutic targets for osteoarthritis.

Fosang AJ, Little CB.

Nat Clin Pract Rheumatol. 2008 Aug;4(8):420-7. doi: 10.1038/ncprheum0841. Epub 2008 Jun 24. Review.

PMID:
18577998
5.

ADAMTS proteoglycanases in the physiological and pathological central nervous system.

Lemarchant S, Pruvost M, Montaner J, Emery E, Vivien D, Kanninen K, Koistinaho J.

J Neuroinflammation. 2013 Oct 31;10:133. doi: 10.1186/1742-2094-10-133. Review.

6.

Identifying the human aggrecanase.

Fosang AJ, Rogerson FM.

Osteoarthritis Cartilage. 2010 Sep;18(9):1109-16. doi: 10.1016/j.joca.2010.06.014. Epub 2010 Jul 13. Review.

Items per page

Supplemental Content

Write to the Help Desk